The FDA approved the medication for the treatment of advanced prostate cancer in U.S. patients on 24th December, 2008.
FDA waxay oggolaatay daawada loogu daweeyo kansarka qanjirka 'prostate' ee bukaanka Mareykanka ee 24th Diseembar, 2008.